Delivery Order SPE2DB25D3109-SPE2DB25FPJST

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.80 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,698.24 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.61 delivery order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product used for respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,327.56 Firm Fixed Price Delivery Order covers the supply of 4565754538 BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product, with an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $2,040.08, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract involves the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of November 1, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,868.84 Firm Fixed Price Delivery Order contract, which has no set-aside designation, is for the provision of the pharmaceutical product "BUDESONIDE-FORMOTEROL 80-4.5 10.2GM". The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is a delivery order, valued at $6,488.76, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a medical product used in healthcare. The contract has a firm fixed price pricing type and a completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $7,165.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.03 firm fixed-price delivery order is for the medical product "BUDESONIDE-FORMOTEROL 80-4.5 10.2GM" and has a completion date of September 15, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPJST
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,176.48 firm fixed-price delivery order supports the supply of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a medical product, with a performance period through January 13, 2025. The award is not designated as a set-aside and is part of a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/13/25, 12:58 AM